[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367923-105":59,"doc-detail-367923-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","3d-bioprinted-liver-cancer-models-derived-from-primary-hepatocytes-for-simulating-cancer-initiation-and-drug-screening","3D-bioprinted liver cancer models derived from primary hepatocytes for simulating cancer initiation and drug screening","","Background: HCC remains one of the most lethal cancers globally, and accurately replicating early tumor-evolution events is a critical challenge. Methods: Early-stage liver cancer cell lines were engineered by introducing distinct oncogene combinations into primary mouse hepatocytes, then modeled using 3D bioprinting with gelatin/alginate bioinks. Results: Oncogene-specific cells showed unique drug-response profiles, including Ras-driven sensitivity to ferroptosis; 3D tissues captured early HCC characteristics and enabled reliable drug screening, outperforming 2D cultures. Conclusions: 2D and 3D models replicate early HCC progression, supporting drug screening and mechanistic insight into carcinogenic initiation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/3d-bioprinted-liver-cancer-models-derived-from-primary-hepatocytes-for-simulating-cancer-initiation-and-drug-screening/367923/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/3d-bioprinted-liver-cancer-models-derived-from-primary-hepatocytes-for-simulating-cancer-initiation-and-drug-screening/367923.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in hepatocellular carcinoma research?","Question",{"text":112,"@type":113},"It targets the difficulty of accurately replicating early events of tumor evolution for HCC and the limited availability of models that capture precursor-like intermediate and transient states.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the early-stage liver cancer models constructed?",{"text":117,"@type":113},"Primary mouse hepatocytes were engineered with distinct oncogene combinations to generate early-stage liver cancer cell lines, and 3D bioprinting was used with gelatin-and-alginate bioinks to build more precise tumor tissue representations.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings were observed about drug responses and model performance?",{"text":121,"@type":113},"Different oncogene combinations produced distinct drug-response profiles, with Ras-driven cells showing heightened ferroptosis sensitivity. The 3D bioprinted tumor tissues preserved early HCC features and demonstrated higher resistance to chemotherapy and targeted therapies than 2D cultures, supporting reliable drug screening.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367923,1790220192,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","DOI: 10.1097/HC9.0000000000000823  \nO R IG INAL ART ICL E  \n3D-bioprinted liver cancer models derived from primary hepatocytes for simulating cancer initiation and drug screening  \nYuanyuan Zhao | Yuxin Li | Wenjie Zhang | Hongyan Jiang | Lina Mao | Runbang He | Yue Ma | Qiangsong Wang | Pengyu Huang  \nState Key Laboratory of Advanced Medical Materials and Devices, Engineering Research Center of Pulmonary and Critical Care Medicine Technology and Device (Ministry of Education), Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Tianjin Institutes of Health Science, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China  \nCorrespondence  \nYue Ma, State Key Laboratory of Advanced Medical Materials and Devices, Engineering Research Center of Pulmonary and Critical Care Medicine Technology and Device (Ministry of Education), Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Tianjin Institutes of Health Science, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China. [Email:](Email: mayue@bme.cams.cn)[ mayue@bme.cams.cn](Email: mayue@bme.cams.cn)  \nQiangsong Wang, State Key Laboratory of Advanced Medical Materials and Devices, Engineering Research Center of Pulmonary and Critical Care Medicine Technology and Device (Ministry of Education), Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Tianjin Institutes of Health Science, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China. [Email:](Email: wangqs@bme.cams.cn)[ wangqs@bme.cams.cn](Email: wangqs@bme.cams.cn)  \nPengyu Huang, State Key Laboratory of Advanced Medical Materials and Devices, Engineering Research Center of Pulmonary and Critical Care Medicine Technology and Device (Ministry of Education), Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Tianjin Institutes of Health Science, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China.  \nEmail: [huangpengyu@yeah.net](huangpengyu@yeah.net)  \n\n|  | Abstract |  |\n| --- | --- | --- |\n| | Background: HCC remains one of the most lethal cancers globally, and accurately replicating the early events of tumor evolution remains a critical challenge.\u003Cbr>Methods: In this study, we developed early-stage liver cancer cell lines by introducing distinct combinations of oncogenes into primary mouse hepatocytes. Using 3D bioprinting technology, combined with bioinks composed of gelatin and alginate, we constructed a more precise representation of liver cancer tissue to better simulate key tumor characteristics.\u003Cbr>Results: Our·findings revealed that different oncogene combinations produced unique drug response profiles, with Ras-driven cells exhibiting heightened sensitivity to ferroptosis. Furthermore, 3D bioprinting tumor tissues derived from transformed hepatocytes effectively captured early HCC characteristics. These models preserved key features of early-stage liver cancer and provided a reliable platform for drug screening. Importantly, the 3D models demonstrated higher resistance to chemotherapy and targeted therapies compared with 2D cultures. Conclusions: In summary, we established both 2D and 3D models that replicate early HCC progression, offering valuable tools for drug screening and advancing our understanding of early carcinogenic mechanisms.\u003Cbr>Keywords: 3D bioprinting, cancer initiation, drug screening, hepatocellular carcinoma, oncogene combinations |  |\n|  |  |  |\n\nAbbreviations: 3DTs, 3D-bioprinted tissues; 5-FU, 5-fluorouracil; DOX, doxorubicin; GSEA, gene set enrichment analysis; ICG, indocyanine green; MDA, malondialdehyde; mHeps, mouse hepatocytes; PI, propidium iodide.  \nYuanyuan Zhao, Yuxin Li, and Wenjie Zhang contributed equally to this work.  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the","cbCaislO2lY5i4sJ","https://ap.wps.com/l/cbCaislO2lY5i4sJ","pdf",2539307,15,"English","# Introduction\n## Background and challenge of modeling early HCC events","[{\"question\":\"What problem does the study address in hepatocellular carcinoma research?\",\"answer\":\"It targets the difficulty of accurately replicating early events of tumor evolution for HCC and the limited availability of models that capture precursor-like intermediate and transient states.\"},{\"question\":\"How were the early-stage liver cancer models constructed?\",\"answer\":\"Primary mouse hepatocytes were engineered with distinct oncogene combinations to generate early-stage liver cancer cell lines, and 3D bioprinting was used with gelatin-and-alginate bioinks to build more precise tumor tissue representations.\"},{\"question\":\"What key findings were observed about drug responses and model performance?\",\"answer\":\"Different oncogene combinations produced distinct drug-response profiles, with Ras-driven cells showing heightened ferroptosis sensitivity. The 3D bioprinted tumor tissues preserved early HCC features and demonstrated higher resistance to chemotherapy and targeted therapies than 2D cultures, supporting reliable drug screening.\"}]","3D-bioprinted liver cancer models derived from primary hepatocytes for simulating cancer initiation and drug screening | PDF",1790173335,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbf7157188dad63df2312611acafb8f8.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1396b8c601eb60d6456bbae4da74414.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/822e098274201c886d73231b2c77fdc2.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/639c85bd2024ca6f17c1cf74141bab6d.webp",980,1292]